Company Overview and News

 
Essel Propack Limited - Updates

2018-10-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
ESSELPRO 500135

 
Minda Industries is range-bound

2018-09-30 premium.thehindubusinessline
Minda Industries (₹354.3): Following a strong rally in 2016 and 2017, the stock of Minda Industries met with a key resistance in the ₹440-450 band in December 2017. Since then, the stock has been on a sideways consolidation phase in the ₹350-450 range.
ESSELPRO MINDAIND 532539 500135

1
Deals Buzz: Troubled IL&FS plans to raise Rs 30, 000 crore by selling 25 assets

2018-09-25 livemint
Mint brings to you your daily dose of deals news reported from newsrooms across the country
ESSELPRO 500135 IX

 
Amcor, Huhtamaki in talks to acquire Essel Propack

2018-09-24 livemint
Mumbai: Promoters of Essel Propack Ltd, which is part of the $4.2 billion Essel Group, are in preliminary talks to sell a controlling stake in the company, said two people directly aware of the development, requesting anonymity. “The talks are at an early stage with two foreign packaging companies, including Amcor Ltd and Huhtamaki Oyj, but more suitors are likely to join the talks,” said the first person.
ESSELPRO 500135 AMCRY MS

1
An evening walk down Dalal Street | Sea of red on D-Street! Sensex down over 500 points, Nifty gives up 11,300

2018-09-11 moneycontrol
Bears painted the town red on Tuesday as a combination of weak rupee, high crude prices, trade war concerns, and a global selloff crashed the market. The Nifty managed to give up 11,300, falling over 150 points, while the Sensex shed over 500 points.
YESBANK DB IBN ESSELPRO 532648 YYBKY 533278 ICICIBANK 500470 TTST TATASTEEL TATLY HDB 532174 500180 500135 HDFCBANK CLNDY COALINDIA

 
Essel Propack gains 2%, to issue commercial paper worth Rs 60 crore

2018-09-11 moneycontrol
Share price of Essel Propack added 2.5 percent intraday Tuesday as company is issuing commercial papers (CP) for Rs 60 crore on private placement basis.
ESSELPRO 500135

 
Essel Propack Limited - Updates

2018-09-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
ESSELPRO 500135

 
Essel Propack Limited - Updates

2018-08-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
ESSELPRO 500135

 
Essel Propack (₹124.5): Buy

2018-08-28 premium.thehindubusinessline
Yoganand D Investors with a short-term perspective can buy the stock of Essel Propack at current levels. On Tuesday, the stock jumped 4.8 per cent accompanied with an extraordinary volume, breaking above a significant medium-term resistance at ₹120.
ESSELPRO 500135

 
Essel Propack Limited - Updates

2018-08-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
ESSELPRO 500135

 
Essel Propack Limited - News Verification

2018-08-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
ESSELPRO 500135

 
Essel Propack Limited - News Verification

2018-08-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
ESSELPRO 500135

 
Essel Propack Limited - Appointment

2018-08-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
ESSELPRO 500135

 
Essel Propack Limited - Appointment

2018-08-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
ESSELPRO 500135

 
Essel Propack Limited - Updates

2018-07-26 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
ESSELPRO 500135

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...